Antifungal drug resistance among Candida species: Mechanisms and clinical impact

  • Chiu Y
  • Chang S
  • Hsueh P
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The epidemiology of Candida infections has changed in recent years. Although Candida albicans is still the main cause of invasive candidiasis in most clinical settings, a substantial proportion of patients is now infected with non-albicans Candida species. The various Candida species vary in their susceptibility to the most commonly used antifungal agents, and the intrinsic resistance to antifungal therapy seen in some species, along with the development of acquired resistance during treatment in others, is becoming a major problem in the management of Candida infection. A better understanding of the mechanisms and clinical impact of antifungal drug resistance is essential for the efficient treatment of patients with Candida infection and for improving treatment outcomes. Herein, we report resistance to the azoles and echinocandins among Candida species.

Author-supplied keywords

  • Amphotericin B
  • Antifungal drug resistance
  • Antifungal resistance
  • Azoles
  • Candida
  • Candida spp.
  • Echinocandins
  • Fungemia
  • K. ohmeri
  • Susceptibility testing
  • acquired immunodeficiency syndrome
  • amphotericin b
  • aquatic environments
  • candida
  • colonization
  • fungal drug resistance
  • fungemia
  • kodamaea ohmeri
  • microbial sensitivity tests
  • premature neonate
  • trichosporon mucoides

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Yu-Shin Chiu

  • Shan-Chwen Chang

  • Po-Ren Hsueh

  • Jiun-Ling Wang

  • Hsin-Yun Sun

  • Yee-Chun Chen

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free